Published in Br Med J (Clin Res Ed) on October 30, 1982
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med (1982) 1.18
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet (1982) 1.10
The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med (1982) 0.99
Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. Proc Natl Acad Sci U S A (1982) 0.93
Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc (1979) 0.92
Outbreak of Coxsackie A1 gastroenteritis: a complication of bone-marrow transplantation. Lancet (1982) 0.79
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81
Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80
Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80
Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79
Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79
Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79
Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus. Mutat Res (1987) 0.78
Lymphocyte function and disease. Br Med J (1978) 0.77
Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med (1986) 0.77
Sensitivity of lymphocytes from patients with systemic lupus erythematosus to the induction of sister chromatid exchanges by alkylating agents and bromodeoxyuridine. Ann Rheum Dis (1987) 0.77
A viral aetiology for juvenile chronic arthritis? Br J Rheumatol (1988) 0.77
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol (1995) 0.77
Cryoglobulins and the immunopathological manifestations of autoimmune disease. Clin Exp Immunol (1992) 0.76
Effects of immunosuppression on herpes simplex virus growth in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1983) 0.75
Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.75
Abnormal lymphocyte function is secondary to drug-induced autoimmunity. Ann Rheum Dis (1976) 0.75
Sex hormones, autoimmune diseases, and immune responses. BMJ (1991) 0.75
Fate of herpes simplex virus in lymphocytes from blood and joint effusions of systemic and pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1983) 0.75
Sister-chromatid exchange frequencies in lymphocytes of controls and patients with connective tissue diseases. Mutat Res (1986) 0.75
Response of the thymus and immunologically induced lymphopenia. Proc Soc Exp Biol Med (1967) 0.75
Infection with Epstein-Barr virus. Br Med J (1979) 0.75
Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment. Postgrad Med J (1980) 0.75
Graft versus host diseases: new versions of old problems? Br Med J (Clin Res Ed) (1985) 0.75
Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75
What is clinical immunology? J Clin Pathol (1981) 0.75
AIDS and CFS/ME. Clin Med (2003) 0.75
Anti-thymocyte globulin in scleroderma. Rheumatology (Oxford) (2001) 0.75
Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75
Chlorambucil induced chromosome damage in juvenile chronic arthritis. Arch Dis Child (1985) 0.75
Sister chromatid exchange frequencies in patients with scleroderma and their relatives. Ann Rheum Dis (1986) 0.75